Radboud universitair medisch centrum Stichting — Sponsor Intelligence | 52 EU Trials

Filter these 52 trials by condition, phase, country and more.

Open in Search →

52 Registered trials

23 Recruiting

13 Completed trials

7 Countries active

92 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 5 Phase II/III: 4 Phase II: 14 Phase I/II: 2 Phase III/IV: 5 Phase IV: 17 Phase I: 1 Phase I (Other): 2 Phase I (FiH): 1 Other: 1

Oversight events:

3 serious breaches 1 urgent safety measure across 3 trials

View oversight register →

100%

13 of 13 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Immune system disorder 1 Sjogren´s syndrome 1 Primary hyperaldosteronism 1

Top IMPs

COLCHICINE 3 OBINUTUZUMAB 2 SODIUM CHLORIDE 2 ABACAVIR SULFATE 1 ABACAVIR SULFATE, LAMIVUDINE 1 ACETYLSALICYLIC ACID 1 ALDESLEUKIN 1 AMPHOTERICIN B 1 ATAZANAVIR 1 ATOMOXETINE 1 BARICITINIB 1 BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX 1

All trials

52 total

Research into existing medicines to reduce aging, pain, and inflammation in osteoarthritis. Not authorised

2025-524885-12-00 Phase II 1 country BARICITINIB; COLCHICINE; DOLUTEGRAVIR; METFORMIN HYDROCHLORIDE
Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial Pending

2024-513486-39-00 Phase III 1 country COLCHICINE
Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS) Pending

2024-514013-34-00 Phase IV 1 country
The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study Pending

2024-516279-34-00 Phase IV 1 country OXYGEN
Fast awakening from general anesthesia, an observational intervention study in healthy volunteers Pending

2024-516415-24-03 Phase IV 1 country FLUMAZENIL; NALOXONE HYDROCHLORIDE; ROCURONIUM BROMIDE; SUFENTANIL CITRATE; SUGA…
A phase 2 trial of capecitabine for recurrent and/or metastatic salivary duct carcinoma – CAESAR trial Pending

2024-516956-16-01 Phase II/III 1 country
Image-Verapamil SR in Adults with Type 1 Diabetes (Image-VER-A-T1D) Pending

2024-518554-17-00 Phase II 2 countries
Ultimate dePletion of autoReactive b cells using Obinutuzumab from sjÖgren's syndrome affected Tissues study- UPROOT study Pending

2024-519884-16-00 Phase II 1 country OBINUTUZUMAB
Imaging beta cells after gestational diabetes Pending

2024-520392-27-00 Phase II 1 country
Research into the effect of Obinutuzumab on the level of PLA2R antibodies in patients with membranous nephropathy. Pending

2025-521139-35-01 Phase II 1 country OBINUTUZUMAB
The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending

2025-521770-34-00 Phase I (Other) 1 country AMPHOTERICIN B
T cell imaging in kidney transplantation (TIK) Pending

2025-522490-11-00 Phase I (Other) 1 country ZIRCONIUM (89ZR) CREFMIRLIMAB BERDOXAM
Healing Diabetic Foot Ulcers with Semaglutide Pending

2025-524738-24-00 Phase IV 1 country SEMAGLUTIDE
PET imaging For eaRly predictiOn of respoNse to neoadjuvanT tReatment in lUNg caNcER Pending

2025-524791-30-00 Phase I/II 2 countries
A clinical study investigating modafinil for the treatment of severe fatigue in patients with inflammatory bowel disease (MODIFI-IBD trial) Pending

2026-525163-41-00 Phase II/III 1 country MODAFINIL
REpurposed drug evaluation for DEceleration of immunE aging & Mitigation of chronic inflammation (REDEEM) Pending

2026-526084-38-00 Phase II 1 country
Insulin nasal spray to prevent delirium after cardiac surgery Recruiting

2025-524680-21-00 Phase II/III 1 country INSULIN HUMAN; SODIUM CHLORIDE
Click-cleavable imaging in HER2-positive cancers (CleavHER trial). Recruiting

2025-520673-39-00 Phase I 1 country
Pharmacologically modulating the noradrenergic arousal system to reduce freezing of gait in Parkinson’s disease: a multi-center and multi-mo… Recruiting

2024-516756-18-00 Phase III 1 country ATOMOXETINE
Anti-inflammatory drug to prevent complications in type 1 diabetes Recruiting

2025-521397-34-00 Phase III/IV 1 country COLCHICINE
ISEE-RCC study Recruiting

2024-514181-39-00 Phase III 1 country GALLIUM (68GA) GOZETOTIDE; ZIRCONIUM (89ZR) GIRENTUXIMAB
Shorter weaning from invasive ventilation with levosimendan: a randomized, double-blind, multicenter study in critically ill patients. Recruiting

2024-518810-23-00 Phase IV 1 country LEVOSIMENDAN; PANTOTHENATE SODIUM, RIBOFLAVIN SODIUM PHOSPHATE, BIOTIN, CYANOCOB…
Efficacy and safety of repeated Rituximab infusions in patients with Active Systemic SClerosis and background medication, a one year randomi… Recruiting

2025-520483-17-01 Phase IV 1 country RITUXIMAB; SODIUM CHLORIDE
Efficacy of Reduced Gadolinium Dose in Contrast-Enhanced Breast MRI Recruiting

2024-518549-27-00 Phase III/IV 1 country GADOTERIC ACID

Showing 1–24 of 52 trials

← All sponsors A–Z